From glucose metabolism to pyroptosis: the regulatory role of the CD2AP/Nephrin axis in podocyte injury in diabetic nephropathy.
文献摘要
Diabetic nephropathy (DN) is a major complication of diabetes, characterized by podocyte injury and progressive renal function decline. The CD2AP/Nephrin axis is crucial for podocyte integrity, yet its involvement in glycolysis-triggered pyroptosis during DN remains unclear. This study explored the regulatory mechanism of the CD2AP/Nephrin axis in high glucose-induced podocyte injury using MPC-5 cells and DN mice. CD2AP overexpression, Disulfiram-mediated pyroptosis inhibition, CD2AP knockdown, and CD2AP overexpression combined with nephrin knockdown rescue experiments were performed. Molecular assays including Western blot, immunofluorescence, ELISA, and histopathological staining were applied to detect pyroptosis markers, glycolysis indicators, and renal function parameters. High glucose disrupted the CD2AP/Nephrin axis, activated caspase-1-dependent pyroptosis, and impaired GLUT4-mediated glucose transport in MPC-5 cells. CD2AP overexpression reversed high glucose-induced upregulation of glycolytic products (lactate, pyruvate) and key enzymes (hexokinase, phosphofructokinase, pyruvate kinase), while reducing pyroptosis markers-effects, which were further enhanced by Disulfiram. Conversely, CD2AP knockdown exacerbated glycolytic overload, NLRP3 inflammasome activation, and pyroptotic cell death. Mechanistically, nephrin knockdown abrogated CD2AP's protective effects on glycolysis regulation and pyroptosis inhibition, confirming nephrin dependence. In DN mice, CD2AP overexpression alleviated hyperglycemia, proteinuria, renal dysfunction (elevated Scr, BUN, reduced Ccr), glomerular hypertrophy and fibrosis, and inhibited GSDMD-mediated pyroptosis via GLUT4 regulation, with Disulfiram enhancing these effects. CD2AP regulates glycolysis-triggered podocyte pyroptosis through the Nephrin/GLUT4 axis, providing a potential therapeutic target for DN.